Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Possible approaches to the use of phospholipid preparations as membrane cholesterol receptors

  • 13 Accesses

  • 1 Citations

This is a preview of subscription content, log in to check access.

Literature Cited

  1. 1.

    L. G. Artemova, T. I. Torkhovskaya, B. G. Khodzhakuliev, et al., Byull. Éksp. Biol. Med., No. 8, 230 (1984).

  2. 2.

    E. A. Borodin, M. É. Lanio, S. S. Markin, et al., Vopr. Med. Khimii, No. 2, 75 (1984).

  3. 3.

    A. N. Klimov, Proceedings of the 4th All-Union Congress of Cardiologists [in Russian], Moscow (1986), p. 13.

  4. 4.

    T. I. Torkhovskaya, E. A. Gorbatenkova, V. A. Dudaev, et al., Vopr. Med. Khimii, No. 2, 101 (1986).

  5. 5.

    M. Bartholome, M. E. Baulet, B. Lassere, and B. Jacott, Biochim. Biophys. Acta,664, 327 (1981).

  6. 6.

    S. Eisenberg, J. Lipid Res.,25, 1015 (1984).

  7. 7.

    J. Schneider, Therapeutic Selectivity and Risk Benefit Assessment of Hypolipidemic Drugs, ed. by G. Ricci et al., New York (1982), p. 263.

  8. 8.

    T. I. Torkhovskaya (T. J. Torchovskaya), E. M. Khalilov, and A. J. Archakov (A. I. Archakov), Human Atherosclerosis, Vol. 2, London (1986), pp. 129–148.

  9. 9.

    K. J. Williams and A. M. Scanu, Biochim. Biophys. Acta,875, 183 (1986).

  10. 10.

    O. Zierenberg, Phospholipids and Atherosclerosis, New York (1983), pp. 175–190.

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Khalilov, É.M., Torkhovskaya, T.I., Fortinskaya, E.S. et al. Possible approaches to the use of phospholipid preparations as membrane cholesterol receptors. Bull Exp Biol Med 107, 510–512 (1989). https://doi.org/10.1007/BF00842392

Download citation

Key Words

  • atherosclerosis
  • ischemic heart disease
  • cholesterol